Featured companies: Biolipox, Cellpoint Diagnostics, Corum Medical, MediKeeper, Mendel Biotechnology, NanoMed, Orexo, Rules-Based Medicine, Tengion
UPDATED: Expanded the Tengion item, and that’s about it.
Tengion raises $33M for bladder regrowth — Tengion, a Norriton, Pa., biotech focused on regenerating diseased or damaged organs, raised $33 million in a third funding round. Investors included Deerfield Partners, Bain Capital, Johnson & Johnson Development, HealthCap, Quaker BioVentures, Oak Investment Partners, L Capital Partners, Horizon Technology Finance and Oxford Finance.
Tengion is working on growing new bladders for adults and children with spinal bifida or spinal-cord injuries based on cells biopsied from the patients’ own bladders. We mentioned the company briefly here.
OTHER HEADLINES OF NOTE:
- Biomarker lab Rules-Based Medicine gets $25M from private equity (release)
- Cancer-diagnostics firm CellPoint Diagnostics pulls in $11.2M (VentureWire, sub req’d)
- Swedish specialty pharma Orexo to acquire Biolipox for $133M (release)
- Cancer drug, diagnostic maker NanoMed gets $1.5M (VentureWire)
- Biocontrol raises £500 against antibiotic-resistant infections (release>
- Satoris reports potential blood test for Alzheimer’s disease (release)
- Corum Medical raises $225K, seeks $3.5M for anemia test (VentureWire)
- Mendel Biotech completes financing round (release)
- Health, wellness Web-tool developer MediKeeper raises funds (release)
One Trackback
8:06 am
VentureBeat » Life sciences briefing: Tuesday, Oct. 16, 2007 said:
[...] RBM makes diagnostics that can test for hundreds of biomarkers at once in a single drop of blood. The idea is to develop tests that will show whether a drug candidate is likely to have bad side effects down th road. Our earlier coverage of the company is here and here. [...]